TREVIA MET XR 100/1000MG TAB 1`S

TREVIA MET XR combines sitagliptin and metformin HCl in an extended-release formulation designed to help manage type 2 diabetes. Sitagliptin works by increasing insulin release when blood sugar is high, while metformin reduces glucose production and improves insulin sensitivity. This dual-action tablet offers convenient once-daily dosing to support better glycemic control. Suitable for patients requiring combination therapy for effective diabetes management.